1.01-16x9-GVB-Biopharma-KK-123911 (1).png
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
26 oct. 2023 08h30 HE | 22nd Century Group, Inc
BUFFALO, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and...
22nd Century Group logo.jpg
22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies
05 avr. 2023 08h30 HE | 22nd Century Group, Inc
Launches Turn-Key Contract Development and Manufacturing Plus Distribution (CDMO+D) Solution for Industry Leading Hemp/Cannabis Brands Highly Accretive Transformative Deal Utilizes Entire 22nd...
22nd Century Group logo.jpg
22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands
16 nov. 2022 09h25 HE | 22nd Century Group, Inc
BUFFALO, N.Y., Nov. 16, 2022 (GLOBE NEWSWIRE) -- GVB Biopharma, a 22nd Century Group company (Nasdaq: XXII), today announced that it has opened a new, strategically-located distribution facility in...
22nd Century Group logo.jpg
22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas
15 nov. 2022 09h25 HE | 22nd Century Group, Inc
BUFFALO, N.Y., Nov. 15, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group logo.jpg
22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences
14 nov. 2022 08h19 HE | 22nd Century Group, Inc
BUFFALO, N.Y., Nov. 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group logo.jpg
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022
08 nov. 2022 06h00 HE | 22nd Century Group, Inc
Accelerating VLN® Sales in Colorado and Illinois, Launching in Four Corners States to Capture Market Share and VolumeGVB Biopharma Acquisition Growing Revenue on Increased VolumesThird Quarter Net...
22nd Century Group logo.jpg
22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New Mexico
26 oct. 2022 09h25 HE | 22nd Century Group, Inc
Combined with Ongoing Launch in Colorado, VLN® Will Be Available in All “Four Corners” StatesUtah and New Mexico Join Colorado as VLN® States with Favorable MRTP Excise Tax Programs BUFFALO, N.Y.,...
22nd Century Group logo.jpg
22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26
18 oct. 2022 09h20 HE | 22nd Century Group, Inc
BUFFALO, N.Y., Oct. 18, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group logo.jpg
22nd Century Group (Nasdaq: XXII) to Participate in the Dawson James Small Cap Growth Conference on October 12
06 oct. 2022 16h05 HE | 22nd Century Group, Inc
BUFFALO, N.Y., Oct. 06, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group logo.jpg
First Cigarette Authorized by FDA to “Help You Smoke Less” Now Available Across Colorado
06 oct. 2022 09h30 HE | 22nd Century Group, Inc
VLN® cigarettes from 22nd Century Group contain 95% less nicotine than conventional cigarettes, greatly reducing nicotine consumption to help smokers smoke less; support State and FDA goals of...